首页 | 本学科首页   官方微博 | 高级检索  
     

垂体瘤转化基因1(PTTG1)的表达变化对人前列腺癌细胞LNCaP生长增殖的影响
引用本文:朱绪辉,毛泽斌,孙文超,那彦群,郭应禄,辛殿祺. 垂体瘤转化基因1(PTTG1)的表达变化对人前列腺癌细胞LNCaP生长增殖的影响[J]. 中国生物化学与分子生物学报, 2005, 21(5): 678-683
作者姓名:朱绪辉  毛泽斌  孙文超  那彦群  郭应禄  辛殿祺
作者单位:1. 北京大学第一医院泌尿外科,北京大学泌尿外科研究所,北京,100034
2. 北京大学医学部生物化学与分子生物学系,北京 100083
3. 清华大学理学院生物科学与技术系,北京,100084
基金项目:国家自然科学基金(No.30171027)资助~~
摘    要:垂体肿瘤转化基因1(PTTG1)具有促进肿瘤生长和转移的作用.通过上调或下调基因表达的策略,观察PTTG1基因对人前列腺癌细胞株LNCaP细胞生长增殖的影响.利用PCR技术分离出PTTG1全长cDNA,分别正向和反向插入真核表达载体pIRES2-EGFP,重组载体分别命名为正义PTTG1-S/pIRES2-EGFP(即pI-P-S)和反义PTTG1-AS/pIRES2-EGFP(即pI-P-AS),将这两种重组载体稳定转染LNCaP细胞,通过流式细胞仪和MTT法分别检测了细胞周期和细胞增殖的情况.转染正义PTTG1后处于S期和G2期的细胞明显增加,细胞生长增殖能力增强;相反,转染反义PTTG1后处于S期和G2期细胞明显减少,细胞生长增殖能力减弱(P<0.05).结果表明,PTTG1能明显改变人前列腺癌细胞株LNCaP的细胞周期和细胞生长增殖能力,它的异常表达可能参与前列腺癌细胞生长增殖过程.

关 键 词:垂体瘤转化基因1  前列腺肿瘤  细胞增殖  
收稿时间:2005-10-20
修稿时间:2004-12-13

Expression and Biological Effect of Pituitary Tumor Transforming Gene 1 On Human Prostate Cancer Cell Line LNCaP
ZHU Xu-Hui,MAO Ze-Bin,SUN Wen-Chao,NA Yan-Qun,GUO Ying-Lu,XIN Dian-Qi. Expression and Biological Effect of Pituitary Tumor Transforming Gene 1 On Human Prostate Cancer Cell Line LNCaP[J]. Chinese Journal of Biochemistry and Molecular Biology, 2005, 21(5): 678-683
Authors:ZHU Xu-Hui  MAO Ze-Bin  SUN Wen-Chao  NA Yan-Qun  GUO Ying-Lu  XIN Dian-Qi
Affiliation:( 1) Department of Urology, Peking University First Hospital, Institute of Urology, Peking University, Beijing 100034, China; 2) Department of Biochemistry and Molecular Biology,Peking University Health Science Center, Beijing 100083, China; 3) Department of Biological Sciences and Biotechnology, Tsinghua University, Beijing 100084, China
Abstract:Pituitary tumor transforming gene 1 (PTTG1) is a proto-oncogene and plays roles in promoting tumorigenesis and metastasis. Eukaryotic expression vector expressing full-length sense and anti-sense PTTG1 mRNA and their effect on the biological behavior of human prostate cancer cell line LNCaP were observed. The full-length PTTG1 cDNA fragment was inserted into the eukaryotic vector pIRES2-EGFP in the sense and anti-sense direction,named PTTG1-S/pIRES2-EGFP(pI-P-S) and PTTG1-AS/pIRES2-EGFP (pI-P-AS). The two recombinant vectors were transfected into LNCaP by LipofectAMINE2000 respectively. The LNCaP clones stably expressing full-length recombinant PTTG1-S/pIRES2-EGFP(sense) or PTTG1-AS/pIRES2-EGFP (anti-sense) were screened with G418.The changes of cell cycle progression and proliferation were analyzed by flow cytometry and MTT methods, respectively. The cell cycle progression was increased during S and peaked at G-2 phase, and cell proliferation was accelerated in sense-transfected cells. In contrast the cell cycle progression was decreased during S and G-2 phase, and cell proliferation was reduced in anti-sense-transfected cells as compared with control cells,(P<0.05). The results indicated that PTTG1 may change the cell cycle progression and improve the potential of cell proliferation in LNCaP cell. These data also suggested that PTTG1 has potential to play an important role in the proliferation of prostate cancer cell.
Keywords:pituitary tumor transforming gene1 (PTTG1)  prostate cancer   cell proliferation
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国生物化学与分子生物学报》浏览原始摘要信息
点击此处可从《中国生物化学与分子生物学报》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号